{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:58:35Z","timestamp":1778943515963,"version":"3.51.4"},"reference-count":18,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science, Technology and Innovation (MCTI)","award":["Rede Virus - No number"],"award-info":[{"award-number":["Rede Virus - No number"]}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de Ensino Superior","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["141844\/2019-1"],"award-info":[{"award-number":["141844\/2019-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["305628\/2020-8"],"award-info":[{"award-number":["305628\/2020-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","award":["2016\/00194-8, 2020\/04558-0 and 2017\/26980-0"],"award-info":[{"award-number":["2016\/00194-8, 2020\/04558-0 and 2017\/26980-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundo de Apoio ao Ensino, Pesquisa e Extens\u00e3o from UNICAMP","award":["2266\/20"],"award-info":[{"award-number":["2266\/20"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Previous studies have indicated that antibody responses can be robustly induced after the vaccination in individuals previously infected by SARS-CoV-2. To evaluate anti-SARS-CoV-2 humoral responses in vaccinated individuals with or without a previous history of COVID-19, we compared levels of anti-SARS-CoV-2 antibodies in the sera from 21 vaccinees, including COVID-19-recovered or -na\u00efve individuals in different times, before and after immunization with an inactivated COVID-19 vaccine. Anti-SARS-CoV-2-specific antibodies elicited after COVID-19 and\/or immunization with an inactivated vaccine were measured by ELISA and Plaque Reduction Neutralizing assays. Antibody kinetics were consistently different between the two vaccine doses for na\u00efve individuals, contrasting with the SARS-CoV-2-recovered subjects in which we observed no additional increase in antibody levels following the second dose. Sera from SARS-CoV2-na\u00efve individuals had no detectable neutralizing activity against lineage B.1 SARS-CoV-2 or Gamma variant five months after the second vaccine dose. Contrarily, SARS-CoV-2-recovered subjects retained considerable neutralizing activity against both viruses. We conclude that a single inactivated SARS-CoV-2 vaccine dose may be sufficient to induce protective antibody responses in individuals with previous history of SARS-CoV-2 infection.<\/jats:p>","DOI":"10.3390\/v14030510","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T22:53:56Z","timestamp":1646261636000},"page":"510","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Previous Infection with SARS-CoV-2 Correlates with Increased Protective Humoral Responses after a Single Dose of an Inactivated COVID-19 Vaccine"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-6678","authenticated-orcid":false,"given":"Fl\u00e1via F.","family":"Bagno","sequence":"first","affiliation":[{"name":"Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A. F.","family":"Andrade","sequence":"additional","affiliation":[{"name":"Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6101-660X","authenticated-orcid":false,"given":"Sarah A. R.","family":"S\u00e9rgio","sequence":"additional","affiliation":[{"name":"Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2818-1301","authenticated-orcid":false,"given":"Pierina L.","family":"Parise","sequence":"additional","affiliation":[{"name":"Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, University of Campinas, Campinas 13083-862, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-058X","authenticated-orcid":false,"given":"Daniel A.","family":"Toledo-Teixeira","sequence":"additional","affiliation":[{"name":"Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, University of Campinas, Campinas 13083-862, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo T.","family":"Gazzinelli","sequence":"additional","affiliation":[{"name":"Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil"},{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz, Centro de Pesquisas Ren\u00e9 Rachou, Belo Horizonte 30190-002, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana P. S. M.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2588-2842","authenticated-orcid":false,"given":"Santuza M. R.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3602-8550","authenticated-orcid":false,"given":"Fabiana","family":"Granja","sequence":"additional","affiliation":[{"name":"Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, University of Campinas, Campinas 13083-862, Brazil"},{"name":"Biodiversity Research Center, Federal University of Roraima, Boa Vista 72000-000, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4996-3153","authenticated-orcid":false,"given":"Jos\u00e9 L.","family":"Proen\u00e7a-M\u00f3dena","sequence":"additional","affiliation":[{"name":"Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, University of Campinas, Campinas 13083-862, Brazil"},{"name":"Experimental Medicine Research Cluster, State University of Campinas, Campinas 13083-862, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1416-8694","authenticated-orcid":false,"given":"Flavio G.","family":"da Fonseca","sequence":"additional","affiliation":[{"name":"Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.15585\/mmwr.mm7037e1","article-title":"Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status\u201413 U.S. Jurisdictions, April 4\u2013July 17, 2021","volume":"70","author":"Scobie","year":"2021","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/d41586-021-01762-w","article-title":"COVID vaccines to reach poorest countries in 2023\u2014Despite recent pledges","volume":"595","author":"Padma","year":"2021","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Montero, C., Fraile-Mart\u00ednez, O., Bravo, C., Torres-Carranza, D., Sanchez-Trujillo, L., G\u00f3mez-Lahoz, A.M., Guijarro, L.G., Garc\u00eda-Honduvilla, N., As\u00fansolo, A., and Bujan, J. (2021). An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines, 9.","DOI":"10.3390\/vaccines9050433"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/d41586-021-01497-8","article-title":"WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic","volume":"594","author":"Mallapaty","year":"2021","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"n2015","DOI":"10.1136\/bmj.n2015","article-title":"Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of COVID-19 in Brazil: Test negative case-control study","volume":"374","author":"Ranzani","year":"2021","journal-title":"BMJ"},{"key":"ref_7","unstructured":"(2021, September 27). Who Coronavirus Dashboard. Available online:https:\/\/covid19.who.int\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.abg9175","article-title":"mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"372","author":"Stamatatos","year":"2021","journal-title":"Science"},{"key":"ref_9","first-page":"eabi8961","article-title":"Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals","volume":"7","author":"Samanovic","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104569","DOI":"10.1016\/j.jcv.2020.104569","article-title":"Comparison of different serological assays for SARS-CoV-2 in real life","volume":"130","author":"Brochot","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","article-title":"Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2","volume":"27","author":"Ebinger","year":"2021","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bagno, F.F., S\u00e9rgio, S.A.R., Figueiredo, M.M., Godoi, L.C., Andrade LA, F., Salazar, N.C., Soares, C.P., Aguiar, A., Almeida, F.J., and da Silva, E.D. (2021). Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19. medRxiv.","DOI":"10.1016\/j.jcvp.2022.100101"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1016\/S2666-5247(21)00129-4","article-title":"Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: An immunological study","volume":"2","author":"Souza","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virusres.2014.03.018","article-title":"Serological assays for emerging coronaviruses: Challenges and pitfalls","volume":"194","author":"Meyer","year":"2014","journal-title":"Virus Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41591-021-01469-5","article-title":"Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: A phase 4 trial","volume":"27","author":"Aikawa","year":"2021","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Seow, J., Graham, C., Merrick, B., Acors, S., Steel, K.J.A., Hemmings, O., O\u2019Bryne, A., Kouphou, N., Pickering, S., and Galao, R. (2020). Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv.","DOI":"10.1101\/2020.07.09.20148429"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2000421","DOI":"10.2807\/1560-7917.ES.2020.25.16.2000421","article-title":"Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020","volume":"25","author":"Perera","year":"2020","journal-title":"Eurosurveillance"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2101197","DOI":"10.2807\/1560-7917.ES.2022.27.2.2101197","article-title":"Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021","volume":"27","author":"Kwok","year":"2022","journal-title":"Eurosurveillance"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/3\/510\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:31:04Z","timestamp":1760135464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/3\/510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["v14030510"],"URL":"https:\/\/doi.org\/10.3390\/v14030510","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]}}}